AUSTIN, Texas, Aug. 5, 2025 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene (NYSE: CNC), announced today it invested $18 million in over-the-counter (OTC) items, a Value-added Service (VAS), for members enrolled in either Medicaid or Children's Health Insurance Program (CHIP) from 2020 through 2024. Value-added Services are extra benefits that help provide additional support for low-income families and individuals across all 254 Texas counties.
"The extra benefits we provide our members are critical in supporting their overall health and well-being," said Mitch Wasden, CEO of Superior HealthPlan. "Over the years, we've learned how impactful these over-the-counter items can be to the families we serve, and we're proud to be able to help them fill this need."
As a Superior HealthPlan Value-added Service*, STAR, CHIP, STAR Kids, STAR Health, and some STAR+PLUS members can receive either $25 or $30 for commonly used OTC items every quarter, per member. These include hundreds of items, such as:
Over-the-counter items are just one of the many VAS offerings from Superior. Some members, depending on the program, may also receive:
Value-added Services are updated annually, with new offerings planned for September 1, 2025. To see a list of available OTC items, visit SuperiorHealthPlan.com/OTC.
*Restrictions and limitations may apply.
About Superior HealthPlan
For more than 25 years, Superior HealthPlan has offered high-quality health care to Texans, and is now a leading managed care company providing services to 2 million people. Committed to transforming the health of the communities we serve, one person at a time, Superior supports active local involvement in all 254 Texas counties with 3,500 employees throughout the state. Since 2020, Superior has contributed $11.9 million in grants, sponsorships and employee giving, helping support low-income communities. Superior is a company of Centene, a leading healthcare enterprise that is committed to helping people live healthier lives. For more information, visit www.SuperiorHealthPlan.com.
Last Trade: | US$29.04 |
Daily Change: | 0.66 2.33 |
Daily Volume: | 7,803,803 |
Market Cap: | US$14.260B |
July 29, 2025 July 25, 2025 April 25, 2025 February 24, 2025 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load